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Routine Testing of Folate Levels in Geriatric 
Assessment for Dementia 
To the Editor:-Folate deficiency is well established as a cause of 
megaloblastic anemia, but its relationship to dementia is less certain. 
In 1967, Strachan and Henderson' reported on two patients with 
dementia who were found to have megaloblastic anemias due to folate 
deficiency. Treatment with folic acid cured both the anemia and the 
dementia in one patient and resulted in marked improvement of men- 
tal status in the other patient. Sneath et al' found a significant correla- 
tion between low red-cell folate and severity of dementia on mental 
assessment scores. Since the dissemination of these reports and 
others, folic acid deficiency is usually included in the differential diag- 
nosis of treatable dementias. Thus in many geriatric assessment/eval- 
uation programs serum folate or red-blood-cell folate, or both, are 
measured as part of the routine testing. 
Larson et a13 found the cost of screening blood tests per diagnosis of 
low folate level to be $1,001, but, if determined only in those with 
abnormal CBCs, the cost was reduced somewhat to $842. Thus they 
suggested folate testing be done on a selective basis. In 60 consecutive 
patients with progessive intellectual deterioration, Freemon' found 
folate levels to be "unrewarding." Foxet a15 evaluated 40 patients with 
"senile dementia" with laboratory tests including routine serum folate 
levels. Only two patients had low levels on initial testing, one of whom 
showed a normal level on retesting. The other was treated and showed 
no improvement in his dementia. Mulley,6 in reviewing the differen- 
tial diagnosis of dementia, states "red-cell folate estimations should be 
limited to patients whose diet was grossly inadequate . . . and who 
have megaloblastic anemia." Despite the findings cited above, folate 
levels continue to be listed in the "standard dementia workup."' 
In the Geriatric Assessment Service of the San Francisco Institute on 
Aging at Mount Zion Hospital and Medical Center, we reviewed the 
results of serum and red-blood-cell folate testing for all patients un- 
dergoing outpatient geriatric assessment from January 1985 to July 
1987. One hundred seventy-two patients with a mean age of 77.5 
years were surveyed during that time. Nine of the 172 were found to 
have an anemia, but none of the nine was clearly macrocytic, and none 
was folate-deficient. 
One hundred two patients, or 59.3% of the total, had serum and 
red-cell folate levels obtained. Of the 102 patients tested, only one had 
a low serum folate, and one other had a low red-blood-cell folate. 
Neither of these patients was macrocytic or had an anemia, but both 
had cognitive deficits (as did 72% of the geriatric assessment patients) 
by the usual clinical and mental status testing criteria (Jacob Cognitive 
Capacity Screening and neuropsychological evaluation). The one pa- 
tient with a low serum folate of 2.0 (normalis greater than 2.3 mg/mL) 
had a normal red-blood-cell folate level. The patient with the low 
red-blood-cell folate of 104 (normal is greater than 140 mg/mL cells) 
had a normal serum folate level. 
Thus our experience over a 14-year period in testing 102 patients 
suggests that routine serum of red-blood-cell folate as part of a geriat- 
ric assessment is of questionable benefit. 
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Acute Care in Chronic Care Settings 
To the Editor:-The pilot study of Zimmer et all confirms what has 
long appeared self-evident: that substantial savings can be achieved if 
effective medical and nursing services become available to deal with 
acute care problems in skilled nursing facilities. Such services require 
careful patient evaluation, timely visits by attending physicians, in- 
tensified nursing care, and ready access to specialized diagnostic and 
consultative services. 
The study also takes note of the fact that hospitalization can be 
"highly disruptive, physically and mentally, to the patient and may 
lead to hospital-acquired complications which might not have oc- 
curred otherwise." It should be added that, when circumstances 
allow, better care can often be rendered in a skilled nursing facility by 
personnel who are familiar with each patient's long-term problems, 
than in an acute hospital setting where a frequently overburdened 
staff confronts a confused and/or uncooperative patient for the first 
time. Hospital-acquired complications primarily related to nursing 
care can be life-threatening, and include malnutrition, infected decu- 
biti, catheter sepsis, and aspiration pneumonia. Many additional 
problems are generated by cumbersome restrictions imposed by DRGs 
and utilization review. 
In outlining various kinds of parenteral treatment, no mention was 
made of hypodermoclysis despite an ambiguous reference to "subcu- 
taneous'' therapy. Although hypodermoclysis is virtually unknown 
among a younger generation of physicians and nurses, the procedure 
offers an exceptionally safe, convenient, and effective means of fluid 
replacement where adequate oral intake is not feasible and circum- 
stances make the establishment of an IV line difficult or impractical.' 
Prompt and effective means for rehydrating acutely ill and debilitated 
patients must always be available. 
A final point must be made with respect to physician reimburse- 
ment. As presently constituted, the medicare program has a built-in 
financial incentive favoring hospitalization. Simply put, when a pa- 
tient is hospitalized the attending physician can be virtually certain 
that medicare reimbursement will cover the entire length of the pa- 
tient's stay. Comparable care rendered in a skilled nursing facility 
would invite either a glut of denied payments or an ongoing battle 
with the medicare carrier. By showing that fair and equitable reim- 
bursement at the skilled nursing level can produce a reliable system of 
efficient and cost-effective care, these investigators have performed a 
distinctive service. It is to be hoped that everyone concerned with the 
health of our aging population will give their report serious attention. 
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